Literature DB >> 25756840

Screening for Primary Aldosteronism: Whom and How?

Michael Doumas1,2, Vasilios Athyros1, Vasilios Papademetriou3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25756840      PMCID： PMC8031928          DOI： 10.1111/jch.12521

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  12 in total

1.  Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study.

Authors:  Stella Douma; Konstantinos Petidis; Michael Doumas; Panagiota Papaefthimiou; Areti Triantafyllou; Niki Kartali; Nikolaos Papadopoulos; Konstantinos Vogiatzis; Chrysanthos Zamboulis
Journal:  Lancet       Date:  2008-06-07       Impact factor: 79.321

2.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

Review 3.  Treatment of primary aldosteronism: Where are we now?

Authors:  Asterios Karagiannis
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

Review 4.  Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas.

Authors:  Asterios Karagiannis; Konstantinos Tziomalos; Anna I Kakafika; Vasilios G Athyros; Faidon Harsoulis; Dimitri P Mikhailidis
Journal:  Endocr Relat Cancer       Date:  2008-06-27       Impact factor: 5.678

Review 5.  The current epidemic of primary aldosteronism: causes and consequences.

Authors:  Norman M Kaplan
Journal:  J Hypertens       Date:  2004-05       Impact factor: 4.844

6.  Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline.

Authors:  John W Funder; Robert M Carey; Carlos Fardella; Celso E Gomez-Sanchez; Franco Mantero; Michael Stowasser; William F Young; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-06-13       Impact factor: 5.958

7.  Unadjusted Plasma Renin Activity as a "First-Look" Test to Decide Upon Further Investigations for Primary Aldosteronism.

Authors:  Peter Rye; Alex Chin; Janice Pasieka; Benny So; Adrian Harvey; Gregory Kline
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-10       Impact factor: 3.738

8.  Catheterization during adrenal vein sampling for primary aldosteronism: failure to use (1-24) ACTH may increase apparent failure rate.

Authors:  Gregory A Kline; Benny So; Valerian C Dias; Adrian Harvey; Janice L Pasieka
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-04-11       Impact factor: 3.738

9.  Common secondary causes of resistant hypertension and rational for treatment.

Authors:  Charles Faselis; Michael Doumas; Vasilios Papademetriou
Journal:  Int J Hypertens       Date:  2011-03-02       Impact factor: 2.420

10.  High-probability features of primary aldosteronism may obviate the need for confirmatory testing without increasing false-positive diagnoses.

Authors:  Gregory A Kline; Janice L Pasieka; Adrian Harvey; Benny So; Val C Dias
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-05-27       Impact factor: 3.738
View more
  2 in total

1.  Bypass of confirmatory tests for case detection of primary aldosteronism in leaner patients?

Authors:  Konstantinos Stavropoulos; Konstantinos P Imprialos; Michael Doumas
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-07-18       Impact factor: 3.738

2.  Primary aldosteronism in patients with adrenal incidentaloma: Is screening appropriate for everyone?

Authors:  Konstantinos Stavropoulos; Konstantinos P Imprialos; Niki Katsiki; Konstantinos Petidis; Apostolos Kamparoudis; Panagiotis Petras; Vasiliki Georgopoulou; Stefanos Finitsis; Christodoulos Papadopoulos; Vasilios G Athyros; Michael Doumas; Asterios Karagiannis
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-05-02       Impact factor: 3.738
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.